Live Breaking News & Updates on Affamed Therapeutics Ltd

Stay updated with breaking news from Affamed therapeutics ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate®) First-in-Class Candidate for the Treatment of Intermediate Dry AMD

/PRNewswire/ AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical,. ....

Hong Kong , Dayao Zhao , Hanmi Pharmaceuticals , Affamed Therapeutics Ltd , China National Medical Products Administration , Drug Administration , Allegro Ophthalmic , Hanmi Pharmaceutical Co Ltd , Amed Therapeutics , National Medical Products Administration , Clinical Trial Application , Intermediate Dry Age Related Macular Degeneration , Affamed Therapeutics , Greater China , Intermediate Dry , Special Protocol Assessment , Pharmacist Lim Sung Ki , Hanmi Pharmaceutical , Market Study , Ophthalmic Treatment Market , Affamed Therapeutics Ltd ,

AffaMed Technologies Announces the First Implantation in the China Registrational Clinical Trial of MINI WELL®, the Progressive Extended Depth-of-Focus IOL

/PRNewswire/ AffaMed Technologies ("AffaMed"), a joint venture established between AffaMed Therapeutics and SIFI S.p.A., today announced the completion of. ....

Yi Lu , Chan Yi , Ophthalmic Research Institute , Hospital Of Fudan University , Med Technologies , Affamed Therapeutics , Registrational Clinical Trial , Extended Depth Of Focus , Fudan University , China Registrational Clinical , General Manager , Affamed Technologies , Greater China , Amed Therapeutics , Affamed Therapeutics Ltd ,

AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China

/PRNewswire/ AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to address critical unmet medical needs in. ....

United States , Dayao Zhao , Eli Lilly , International Burden Of Migraine Study , Company Eli Lilly , Affamed Therapeutics Ltd , Mainland China , Amed Therapeutics , National Medical Products Administration , Greater China , Affamed Therapeutics , Pain Headache , International Burden , Migraine Study , Global Burden , Disease Study , Affamed Therapeutics Ltd ,